scholarly journals Maté Tea Inhibits In Vitro Pancreatic Lipase Activity and Has Hypolipidemic Effect on High-fat Diet-induced Obese Mice

Obesity ◽  
2010 ◽  
Vol 18 (1) ◽  
pp. 42-47 ◽  
Author(s):  
Fernanda Martins ◽  
Tatiana M. Noso ◽  
Viviane B. Porto ◽  
Alline Curiel ◽  
Alessandra Gambero ◽  
...  
2014 ◽  
Vol 2 (10) ◽  
pp. 757-763 ◽  
Author(s):  
Dandan Shi ◽  
Chaoyin Chen ◽  
Shenglan Zhao ◽  
Feng Ge ◽  
Diqiu Liu ◽  
...  

2008 ◽  
Vol 3 ◽  
pp. 176-177
Author(s):  
D. Arçari ◽  
W. Bartchewsky ◽  
T.W. dos Santos ◽  
K.A. Oliveira ◽  
D.M. Bastos ◽  
...  

Molecules ◽  
2020 ◽  
Vol 25 (17) ◽  
pp. 4001
Author(s):  
Sen Guo ◽  
Haoan Zhao ◽  
Zhongxiao Ma ◽  
Shanshan Zhang ◽  
Mingrou Li ◽  
...  

Previously we conducted a phytochemical study on the seeds of Fraxinus excelsior and isolated nine secoiridoid compounds with adipocyte differentiation inhibitory activity and peroxisome proliferator activated receptor alpha (PPARα) activation effects. However, the bioactive constituents and functions of Fraxinus mandshurica seeds have not been studied. In the present study, we investigated the secoiridoid compounds in F. mandshurica seed extract (FM) using column chromatography, 1H-NMR, 13C-NMR and HPLC-DAD methods. The pancreatic lipase inhibitory activities of isolated compounds were evaluated in vitro. Additionally, the anti-obesity and gut microbiota modulation effect of FM on high-fat diet-induced obesity in C57BL/6 mice were also studied in vivo. The results showed that 19 secoiridoids were isolated from FM and identified. The total content of secoiridoids in FM reached 181.35 mg/g and the highest content was nuzhenide (88.21 mg/g). All these secoiridoid compounds exhibited good pancreatic lipase inhibitory activity with inhibition rate ranged from 33.77% to 70.25% at the concentration of 100 μM. After obese mice were administrated with FM at 400 mg/kg.bw for 8 weeks, body weight was decreased by 15.81%. Moreover, FM could attenuate the lipid accumulation in serum and liver, relieve the damage in liver and kidney, and extenuate oxidative stress injury and inflammation caused by obesity in mice. FM could also modulate the structural alteration of gut microbiota in obese mice, increasing the proportion of anti-obesity gut microbiota (Bacteroidetes, Bacteroidia, S24-7 and Allobaculum), and reducing the proportion of obesogenic gut microbiota (Firmicutes and Dorea). This study suggests that F. mandshurica seeds or their secoiridoids may have potential for use as a dietary supplement for obesity management.


2017 ◽  
Vol 4 (11) ◽  
pp. 170917 ◽  
Author(s):  
Yanyun Pan ◽  
Dandan Zhao ◽  
Na Yu ◽  
Tian An ◽  
Jianan Miao ◽  
...  

Curcumin is an active component derived from Curcuma longa L. which is a traditional Chinese medicine that is widely used for treating metabolic diseases through regulating different molecular pathways. Here, in this study, we aimed to comprehensively investigate the effects of curcumin on glycolipid metabolism in vivo and in vitro and then determine the underlying mechanism. Male C57BL/6 J obese mice and 3T3-L1 adipocytes were used for in vivo and in vitro study, respectively. Our results demonstrated that treatment with curcumin for eight weeks decreased body weight, fat mass and serum lipid profiles. Meanwhile, it lowered fasting blood glucose and increased the insulin sensitivity in high-fat diet-induced obese mice. In addition, curcumin stimulated lipolysis and improved glycolipid metabolism through upregulating the expressions of adipose triglyceride lipase and hormone-sensitive lipase, peroxisome proliferator activated receptor γ/α (PPARγ/α) and CCAAT/enhancer binding proteinα (C/EBPα) in adipose tissue of the mice. In differentiated 3T3-L1 cells, curcumin reduced glycerol release and increased glucose uptake via upregulating PPARγ and C/EBPα. We concluded that curcumin has the potential to improve glycolipid metabolism disorders caused by obesity through regulating PPARγ signalling pathway.


2018 ◽  
Vol 49 (5) ◽  
pp. 1870-1884 ◽  
Author(s):  
Chian-Jiun Liou ◽  
Ciao-Han Wei ◽  
Ya-Ling Chen ◽  
Ching-Yi Cheng ◽  
Chia-Ling Wang ◽  
...  

Background/Aims: Fisetin is a naturally abundant flavonoid isolated from various fruits and vegetables that was recently identified to have potential biological functions in improving allergic airway inflammation, as well as anti-oxidative and anti-tumor properties. Fisetin has also been demonstrated to have anti-obesity properties in mice. However, the effect of fisetin on nonalcoholic fatty liver disease (NAFLD) is still elusive. Thus, the present study evaluated whether fisetin improves hepatic steatosis in high-fat diet (HFD)-induced obese mice and regulates lipid metabolism of FL83B hepatocytes in vitro. Methods: NAFLD was induced by HFD in male C57BL/6 mice. The mice were then injected intraperitoneally with fisetin for 10 weeks. In another experiment, FL83B cells were challenged with oleic acid to induce lipid accumulation and treated with various concentrations of fisetin. Results: NAFLD mice treated with fisetin had decreased body weight and epididymal adipose tissue weight compared to NAFLD mice. Fisetin treatment also reduced liver lipid droplet and hepatocyte steatosis, alleviated serum free fatty acid, and leptin concentrations, significantly decreased fatty acid synthase, and significantly increased phosphorylation of AMPKα and the production of sirt-1 and carnitine palmitoyltransferase I in the liver tissue. In vitro, fisetin decreased lipid accumulation and increased lipolysis and β-oxidation in hepatocytes. Conclusion: This study suggests that fisetin is a potential novel treatment for alleviating hepatic lipid metabolism and improving NAFLD in mice via activation of the sirt1/AMPK and β-oxidation pathway.


2019 ◽  
Vol 59 (7) ◽  
pp. 1310 ◽  
Author(s):  
Kanokporn Lammasak ◽  
Suwanna Kijpakorn ◽  
Kris Angkanaporn

The aim of the study was to examine the effect of pig bile powder supplementation on the digestibility of nutrients, fat digestion and growth performance of starter broilers fed on a high fat diet. A total of 1110, day-old, male broiler chicks (Arbor Acres) were randomly allocated into six treatment groups with five replicates per treatment. The chicks were fed on a corn-soybean meal basal diet with a starter formulation until Day 14, followed by a grower formulation until Day 21. In group 1 (T1), the basal diet contained 30 g/kg crude palm oil whereas the diet used in group 2 (T2) had 60 g/kg crude palm oil. Chicks in group 3 (T3) were fed on T2 diet supplemented with 5.0 g/kg soy lecithin as the positive control. Chicks in groups 4–6 (T4–T6) received diets used in T2, supplemented with 1.25, 2.5 and 5.0 g/kg lyophilised pig bile powder, respectively. On Days 4, 7, 14 and 21, chicks were killed, portal blood was collected and analysed for fatty acids, pancreas collected for measurement of pancreatic lipase activity, bile and jejunal contents for bile acid determination and ileal content for determining digestibility of fat and protein. The results showed (1) there was no difference in bodyweight and feed intake among T2–T6, (2) pancreatic lipase activity of chicks in T4 and T5 was highest in all periods. Total bile acid concentrations in the gall bladder and jejunum in T4 was lower than those in T2 in all periods, and Days 4 and 7, respectively, (3) digestibility of protein and fat in T3 and T4 was higher in all the period than that of T2, T5 and T6, (4) increased fat content in the diet did not cause a significant increase in any fatty acids in the portal plasma when compared T1 and T2. In conclusion, 2.5 g/kg porcine bile powder supplemented in high fat diet increased pancreatic lipase activity and total bile acid concentrations in gall bladder, resulting in increased ileal digestibility of fat and protein.


Nutrients ◽  
2019 ◽  
Vol 11 (12) ◽  
pp. 3035
Author(s):  
Jiyoung Moon ◽  
Min Jin Ha ◽  
Min-Jeong Shin ◽  
Oh Yoen Kim ◽  
Eun Hye Yoo ◽  
...  

Since arginase has been shown to compete with nitric oxide (NO) synthase, emerging evidence has reported that arginase inhibition improves obesity by increasing NO production. Semen cuscutae (SC), which is a well-known Chinese medicine, has multiple biological functions such as anti-oxidant function and immune regulation. In this study, we investigated whether the SC as a natural arginase inhibitor influences hepatic lipid abnormalities and whole-body adiposity in high-fat diet (HFD)-induced obese mice. The lipid accumulation was significantly reduced by SC treatment in oleic acid-induced hepatic steatosis in vitro. Additionally, SC supplementation substantially lowered HFD-induced increases in arginase activity and weights of liver and visceral fat tissue, while increasing hepatic NO. Furthermore, elevated mRNA expressions of sterol regulatory element-binding transcription factor 1 (SREBP-1c), fatty-acid synthase (FAS), peroxisome proliferator-activated receptor-gamma (PPAR-γ)1, and PPAR-γ2 in HFD-fed mice were significantly attenuated by SC supplementation. Taken together, SC, as a novel natural arginase inhibitor, showed anti-obesity properties by modulating hepatic arginase and NO production and metabolic pathways related to hepatic triglyceride (TG) metabolism.


2018 ◽  
Vol 46 (01) ◽  
pp. 119-136 ◽  
Author(s):  
Sarmila Nepali ◽  
Ji-Yun Cha ◽  
Hyeon-Hui Ki ◽  
Hoon-Yeon Lee ◽  
Young-Ho Kim ◽  
...  

Chrysanthemum indicum (CI) is widely distributed in China and many parts of the tropical world, and has been reported to have antibacterial, antiviral, anti-oxidant and immunomodulatory effects, but no information is available on its effects on high fat diet (HFD)-induced obesity. This was undertaken to investigate the mechanism responsible for the effect of ethyl acetate fraction of CI (CIEA) on adipogenesis, in vitro and in vivo models of obesity. In the in vitro study, differentiating 3T3-L1 cells were treated with media to initiate differentiation (MDI) in the presence or absence of CIEA with different concentrations, and in the in vivo study, C57BL/6 mice were fed with HFD and administered CIEA daily for six weeks. Garcinia cambogia (GC) was used as the positive control, and was administered in the same manner as CIEA. Results showed CIEA reduced HFD-induced body weight gain, epididymal white adipose tissue (eWAT), and liver weight. In addition, CIEA significantly decreased serum lipid profiles, including total cholesterol (TC), triglyceride (TG) and low density lipoprotein cholesterol (LDLc) and increased high density lipoprotein cholesterol (HDLc) levels. Furthermore, CIEA also reduced leptin levels and increased adiponectin levels in serum, and significantly decreased peroxisome proliferator-activated receptor [Formula: see text] (PPAR[Formula: see text]) and CCAAT/enhancer-binding protein (C/EPBs) levels, but increased PPAR[Formula: see text] level and the phosphorylation of AMP-activated protein kinase (AMPK) in eWATs and in the liver tissues of HFD fed obese mice. Taken together, these results indicate CIEA might be beneficial for preventing obesity.


2015 ◽  
Vol 9 (37) ◽  
pp. 919-928
Author(s):  
Carolina Vieira Almeida Erika ◽  
Antonio Pigoso Ac aacute cio ◽  
Fernando de Almeida Alex

Sign in / Sign up

Export Citation Format

Share Document